Vesicular Phospholipid Gels: A Technology Platform

References

• Bachmann D., Brandl M., Gregoriadis G. Preparation of liposomes using a Mini-Lab 8.30 H high-pressure homogenizer. Int. J. Pharm. 1993; 91(1)69–74
   Web of Science ®Google Scholar
• Beijnen J. H., Van der Houwen O. A. G. J., Underberg W. J. M. Aspects of the degradation kinetics of doxorubicin in aqueous solution. Int. J. Pharm. 1986; 32(2–3)123–131
   Google Scholar
• Brandl M. (1998) Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs, Based on the Invited Lectures and Communications presented at the Colloidal Drug Carriers Expert Meeting, 3rd. High-pressure homogenization techniques for the production of liposome dispersions: potential and limitations, Berlin, May 29–31, 1997, 267–294
   Google Scholar
• Brandl M. Liposomes as drug carriers: a technological approach. Biotechno. Ann. Rev. 2001; 7: 59–85
   PubMedGoogle Scholar
• Brandl M., Bachmann D., Drechsler M., Bauer K. H. Liposome preparation by a new high pressure homogenizer Gaulin Micron LAB 40. Drug Dev. Ind. Pharm. 1990; 16(14)2167–2191
   Web of Science ®Google Scholar
• Brandl M., Bachmann D., Reszka R., Drechsler M. Liposomal carrier for active agents. Application, , DE 1996a; 7, (Max-Delbrueck-Centrum fuer Molekulare Medizin, Germany).
   Google Scholar
• Brandl M., Bachmann D., Reszka R., Drechsler M. Unilamellar vesicular lipids for liposomal preparations with high active substance content. Application, US 2002; 14, (Max-Delbrueck-Centrum Fuer Molekulare Medizin, Germany). Cont-in-part of Appl. No PCT/DE95/01162.
   Google Scholar
• Brandl M., Drechsler M., Bachmann D., Bauer K.-H. Morphology of semisolid aqueous phosphatidylcholine dispersions, a freeze fracture electron microscopy study. Chem. Phys. Lip. 1997; 87(1)65–72
   Web of Science ®Google Scholar
• Brandl M., Drechsler M., Bachmann D., Bauer K. H. Three-dimensional networks of liposomes: preparation and electron microscopical characterization. Proc. International Symposium on Controlled Release of Bioactive Materials 1996b; 23: 25–26
   Google Scholar
• Brandl M., Drechsler M., Bachmann D., Tardi C., Schmidtgen M., Bauer K.-H. Preparation and characterization of semi-solid phospholipid dispersions and dilutions thereof. Int. J. Pharm. 1998; 170(2)187–199
   Web of Science ®Google Scholar
• Brandl M., Massing U. Vesicular phospholipid gels. Liposomes, V. P. Torchilin, V. Weisssig. Oxford Press, Oxford 2003; 353–372
   Google Scholar
• Brandl M., Reszka R. Preparation and characterization of phospholipid membrane gels as depot formulations for potential use as implants. Proc. International Symposium on Controlled Release of Bioactive Materials. 1995; 22: 472–473
   Google Scholar
• Brandl M. M., Bachmann D., Drechsler M., Bauer K. H. Liposome preparation using high-pressure homogenizers. Liposome Technology 2nd. 1993; 1: 49–65
   Google Scholar
• Flaten G. E., Dhanikula A. B., Luthman K., Brandl M. Drug permeability across a phospholipid vesicle based barrier: A novel approach for studying passive diffusion. Eur. J. Pharm. Sci. 2006; 27(1)80–90
   Google Scholar
• Grohganz H. Vesicular phospholipid gels as a potential implant system for cetrorelix. University of Tromsoe, Tromsoe 2004; 72, Dr.scient.-thesis.
   Google Scholar
• Grohganz H., Rischer M., Brandl M. Adsorption of the decapeptide Cetrorelix depends both on the composition of dissolution medium and the type of solid surface. Eur. J. Pharm. Sci. 2004a; 21(2–3)191–196
   PubMed Web of Science ®Google Scholar
• Grohganz H., Schlafli O., Rischer M., Brandl M. Development and validation of a HPLC method for routine quantification of the decapeptide Cetrorelix in liposome dispersions. J. Pharm. Biomed. Anal. 2004b; 34(5)963–969
   PubMed Web of Science ®Google Scholar
• Grohganz H., Tho I., Brandl M. Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix. Eur. J. Pharm. Biopharm. 2005; 59(3)439–448
   Google Scholar
• Grohganz H., Ziroli V., Massing U., Brandl M. Quantification of various phosphatidylcholines in liposomes by enzymatic assay. AAPS Pharm. Sci. Tech. 2003; 4(4)E63
   Google Scholar
• Guethlein F. Darstellung und Pruefung von vesikulaeren Phospholipidgelen (VPG) zur Therapie solider Tumoren 2001; 195, Diss. rer. nat. Freiburg, Albert-Ludwigs-Universitaet
   Google Scholar
• Ingebrigtsen L., Brandl M. Determination of the size distribution of liposomes by SEC fractionation, and PCS analysis and enzymatic assay of lipid content. AAPS Pharm. Sci. Tech 2002; 3(2)E7
   Google Scholar
• Moog R. Einschluss von Gemcitabin (dFdC) in vesikuläre Phospholipidgele 1998; 155, Diss. rer. nat. Freiburg, Albert-Ludwigs-Universität: p.
   Google Scholar
• Moog R., Brandl M., Schubert R., Unger C., Massing U. Effect of nucleoside analogs and oligonucleotides on hydrolysis of liposomal phospholipids. Int. J. Pharm. 2000; 206(1–2)43–53
   Google Scholar
• Patel V. B., Misra A., Marfatia Y. S. Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications. Pharm. Dev. Techno. 2000; 5(4)455–464
   PubMed Web of Science ®Google Scholar
• Pavelic Z., Skalko-Basnet N., Schubert R. Liposomal gels for vaginal drug delivery. Int. J. Pharm. 2001; 219(1–2)139–149
   PubMed Web of Science ®Google Scholar
• Paavola A., Kilpelainen I., Yliruusi J., Rosenberg P. Controlled release injectable liposomal gel of ibuprofen for epidural analgesia. Int. J. Pharm. 2000; 199(1)85–93
   PubMed Web of Science ®Google Scholar
• Saetern A. M., Skar M., Braaten A., Brandl M. Camptothecin-catalyzed phospholipid hydrolysis in liposomes. Int. J. Pharm. 2005; 288(1)73–80
   Google Scholar
• Schneider T., Sachse A., Roessling G., Brandl M. Large-scale production of liposomes of defined size by a new continuous high pressure extrusion device. Drug Dev. Ind. Pharm. 1994; 20(18)2787–2807
   Web of Science ®Google Scholar
• Sætern A. M. Parenteral liposome- and cyclodextrin formulations of camptothecin 2004; 58, Dr. scient.-thesis. Tromsoe, University of Tromsoe,
   Google Scholar
• Tardi C. Vesikuläre Phospholipidgele: in-vitro Charakterisierung, Autoklavierbarkeit, Anwendung als Depotarzneiform 1999; 103, Diss. rer. nat. Freiburg, Albert-Ludwigs-Universität,
   Google Scholar
• Tardi C., Brandl M., Schubert R. Erosion and controlled release properties of semisolid vesicular phospholipid dispersions. J. Contr. Rel. 1998; 55(2,3)261–270
   Google Scholar
• Tardi C., Drechsler M., Schubert R., Brandl M. Three-dimensional networks of liposomes: change of properties upon autoclaving. Proc. International Symposium on Controlled Release of Bioactive Materials 1996; 23: 27–28
   Google Scholar
• Unger C., Massing U., Moog R. Method for the production of liposomal substance formulations. Application, DEGermany 1999; 6
   Google Scholar